life sciences

Kilroy Realty Corp's (NYSE:KRC) near-term performance is likely to be impacted by a decline in capitalized interest, according to JPMorgan. The Kilroy Realty Analyst: Analyst Anthony Paolone maintained an Overweight rating, while cutting the price target from $42 to $40. The Kilroy Realty Thesis:...

Charles River Laboratories International Inc (NYSE: CRL) reported third-quarter (Q3) sales of $1.03 billion, an increase of 3.8% Y/Y, beating the consensus of $1 billion. The company reported adjusted EPS of $2.72, beating the Wall Street estimate of $2.37. Acquisitions contributed 0.2%...

Best known as the CEO of Tesla, Elon Musk also wears many other hats with titles of co-founder, owner and CEO pertaining to SpaceX, The Boring Company, Neuralink and social media platform X, formerly known as Twitter. One of the companies co-founded by Musk recently landed a funding round...

JPMorgan Chase & Co. (NYSE: JPM) has launched a healthcare venture-capital practice through its JPMorgan Private Capital arm.  In the first two quarters of 2021, 123 companies raised $5.2 billion in healthcare funding, in New York City alone, according to the New York...

Verily, Alphabet Inc’s (NASDAQ: GOOG) (NASDAQ: GOOGL) life sciences research unit, on Thursday disclosed raising $700 million from existing investors in its latest funding round. What Happened: In addition to parent Alphabet — Silver Lake, Temasek, Ontario Teacher’s Pension Plan...

The Canadian asset management company Brookfield Asset Management Inc (NYSE: BAM) is reshuffling its real estate portfolio with multiple deals. In one deal, it is considering the sale of 2.3 million square feet of life sciences real estate for $3 billion, according to...

Blackstone Group Inc (NYSE: BX) announced the sale of its portfolio company BioMed Realty for $14.6 billion on Thursday, to a group led by existing BioMed investors. BioMed was acquired by Blackstone Real Estate Partners VIII L.P. and co-investors in 2016 and the sale represents a $6.5 billion gain...

Cloud solutions provider for the life sciences industry company Veeva Systems Inc (NYSE: VEEV) reported second-quarter results, which prompted two analysts to become incrementally bullish on the stock. The Analysts Stifel analyst Tom Roderick maintains a Buy rating on Veeva with a price target...

Veeva Systems Inc (NYSE: VEEV), a cloud solution provider for the global life sciences industry, reported Wednesday with third-quarter results that came in better than expected and an encouraging look at the coming fiscal year.   The Analysts Morgan Stanley's Stan Zlotsky maintains an...

Veeva Systems Inc (NYSE: VEEV), a cloud-computing company focused on the pharma and life sciences industry, is an underpriced asset within the broader SaaS universe, according to Morgan Stanley.  The Analyst Morgan Stanley analyst Stan Zlotsky upgraded Veeva Systems from Equal-weight to...

The first part of this Interview, including Martin Headley's comments on the semiconductor industry can be found here. In an exclusive interview with Benzinga, CFO of Brooks Automation (NASDAQ: BRKS), Martin Headley elaborated on the company’s newly launched divisions. “We have recently...